| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 48 |
| 1 | ASPIRIN | 43 |
| 2 | ASPIRIN 325 MG | 42 |
| 3 | ASPIRIN 81 MG | 42 |
| 4 | SIMVASTATIN | 29 |
| 5 | ERGOCALCIFEROL | 28 |
| 6 | ACETAMINOPHEN 500MG | 27 |
| 7 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 27 |
| 8 | ADALIMUMAB | 27 |
| 9 | AMLODIPINE | 27 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIPYRIDAMOLE | 22 | 0.0059 |
| 1 | LIDOCAINE, PRILOCAINE | 1 | 0.0050 |
| 2 | FLURANDRENOLIDE | 1 | 0.0030 |
| 3 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 1 | 0.0021 |
| 4 | CROTAMITON | 1 | 0.0016 |
| 5 | ERDAFITINIB | 2 | 0.0016 |
| 6 | EFINACONAZOLE | 3 | 0.0015 |
| 7 | CYCLOPENTOLATE HYDROCHLORIDE | 1 | 0.0015 |
| 8 | PEXIDARTINIB HYDROCHLORIDE | 1 | 0.0014 |
| 9 | CUPRIC CHLORIDE | 1 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 97 |
| 1 | Kinase Inhibitor [EPC] | 62 |
| 2 | Corticosteroid [EPC] | 56 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 45 |
| 4 | Proton Pump Inhibitor [EPC] | 43 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 36 |
| 6 | Microtubule Inhibitor [EPC] | 29 |
| 7 | Provitamin D2 Compound [EPC] | 28 |
| 8 | Calcium Channel Blocker [EPC] | 27 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 27 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 3 | 0.0014 |
| 1 | Endoglycosidase [EPC] | 2 | 0.0011 |
| 2 | Provitamin D2 Compound [EPC] | 28 | 0.0009 |
| 3 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 4 | Aryl Hydrocarbon Receptor Agonist [EPC] | 1 | 0.0005 |
| 5 | Interleukin-17A Antagonist [EPC] | 18 | 0.0005 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 22 | 0.0003 |
| 7 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 8 | Anticholinergic [EPC] | 4 | 0.0002 |
| 9 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |